Pfizer Ltd. has declared a bumper dividend of Rs 75 per equity share with Rs 10 face value for the financial year 2026, according to an exchange filing on Tuesday.
The company has set July 17, 2026 as the record date to determine eligibility of shareholders for the dividend payout. Additionally, Pfizer informed that the dividend will be paid on or after Aug 4, 2026.
Notably, the pharma giant's net profit for the fourth quarter of FY26 has slumped 39.6% year-on-year to Rs 200 crore as against Rs 331 crore.
On the other hand, revenue from operations rose 6.3% to Rs 629 crore as against Rs 592 crore in the year-ago period. Earnings before interest, taxes, depreciation, and amortisation rose 3.7% to Rs 236 crore from Rs 228 crore. Ebitda margin slipped by 93 basis points to 37.5% from 38.4%.
The company also reported some exceptional item costs for the year-ended March 31, 2026. This includes Rs 41.73 crore towards personnel separation cost of field force and marketing teams as a result of an exclusive Supply and Marketing Agreement with Cipla Ltd, along with provisions of Rs 7.43 crore for the year to accomodate Centre's new labour codes.
Pfizer Q4FY26 Results Highlights (YoY)
Net Profit down 39.6% At Rs 200 crore Vs Rs 331 crore
Revenue up 6.3% At Rs 629 crore Vs Rs 592 crore
Ebitda up 3.7% At Rs 236 crore Vs Rs 228 crore
Ebitda Margin down 93 Bps At 37.5% Vs 38.4%
Pfizer Share Price
Pfizer's stock ended over 3% lower at Rs 4,725.90 apiece on the NSE on Tuesday. This compared to a 1.83% decline in the benchmark in the Nifty index.
The scrip has fallen 5.25% year-to-date but risen 11.21% in the last 12 months.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
